General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov stands near the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484823
The view shows a package of new EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484816
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484814
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484812
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484811
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484810
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484807
Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.04.03.2021#6484808
General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov is pictured at the Scientific Center in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484801
General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov stands at the entrance to the Scientific Center in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484799
Employees talk to each other at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484795
Employees stand at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484793
Head of the Department of Zoonotic Infections and Influenza Alexander Ryzhikov is pictured at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484789
Head of the Department of Zoonotic Infections and Influenza Alexander Ryzhikov is pictured at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484786
The view shows the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484782
Deputy General Director for Scientific Work Elena Gavrilova straightens ьannequin's Personal Protective Equipment (PPE) at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484781
The view shows the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484779
A mannequin, dressed in a Personal Protective Equipment (PPE), stands at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484778
Mannequins, dressed in Personal Protective Equipment (PPE), stand at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484777
Biohazard sign is seen on the entrance door to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484774
The view shows the entrance to the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484773
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484772
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484770
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484769
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484768
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484767
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484765
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484763
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484762
An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484761
Employees work at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484760
An employee is pictured with a background of a billboard in the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.04.03.2021#6484759
